Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.

Br J Cancer · 1992 · PMC1977745 · PMID 1739621

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

How- ever, the highly significant difference observed in sensitivity to the cytolytic activity of A-LAK cells between tumour cell lines (K562 or Daudi) and normal bone marrow cells suggest that A-LAK preferentially kill tumour cells.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.